| 000 | nam a22 7a 4500 | ||
|---|---|---|---|
| 999 |
_c10428 _d10429 |
||
| 003 | BD-DhSUL | ||
| 005 | 20230307162534.0 | ||
| 008 | 230307b2022 uk ||||| |||| 00| 0 eng d | ||
| 020 | _a9780857114327 | ||
| 020 | _a 0857114328 | ||
| 040 | _cBD-DhSUL | ||
| 082 |
_a615.1 _bBNF |
||
| 245 |
_aBNF 84 (British National Formulary) Part-1 : _bSeptember 2022: 84: September 2022 - March 2023 / _cRoyal Pharmaceutical Society |
||
| 260 |
_aUK : _bPharmaceutical Press, _c2022 |
||
| 300 |
_a900 p.; _c23.5 cm. |
||
| 365 |
_aBDT _b1800/- (Part 1 & 2) |
||
| 440 | _vPart-1 | ||
| 526 | _aPharmacy | ||
| 650 | _aDrug | ||
| 710 | _aRoyal Pharmaceutical Society | ||
| 942 |
_2ddc _cSID-BK |
||